Monomeric chemically modified allergens: immunologic and physicochemical characterization

Area of Science:

• Immunology
• Allergy Research
• Biochemistry

Background:

• Allergenic extracts and specific allergens are crucial in allergy research and diagnostics.
• Chemical modification of allergens is explored to reduce their allergenic potency for potential therapeutic applications.

Purpose of the Study:

• To investigate the effects of chemical modification using potassium cyanate (KCNO) on the allergenic potency and immunogenicity of various allergens.
• To evaluate the potential clinical applications of these modified allergens.

Main Methods:

• Allergens (Der p, grass, Parietaria extracts, Par j I, ovalbumin) were chemically modified with KCNO, converting lysine epsilon-amino groups to ureido groups (carbamylation).
• Allergenic potency was assessed using in vitro (RAST inhibition) and in vivo (passive cutaneous anaphylaxis) assays.
• Immunogenicity was evaluated by immunizing rabbits and analyzing IgG antibody cross-reactivity with native allergens via immunoblotting.
• Structural integrity was confirmed using SDS-PAGE analysis to demonstrate preservation of native monomeric dimensions.

Main Results:

• KCNO-modified (carbamylated) allergens exhibited significantly reduced allergenic potency in both in vitro and in vivo tests.
• Despite reduced potency, carbamylated allergens successfully induced IgG antibodies in rabbits that cross-reacted with native allergens.
• SDS-PAGE analysis confirmed that carbamylation preserved the native monomeric size of the allergens, unlike some other chemical modifications.

Conclusions:

• Carbamylation is an effective method for reducing the allergenic potency of proteinaceous allergens.
• Carbamylated allergens retain immunogenicity, inducing cross-reactive IgG antibodies, suggesting potential for immunotherapy.
• The preservation of native monomeric dimensions is a key feature of carbamylated allergens, potentially advantageous for clinical applications.